NCT03151148View on ClinicalTrials.gov

Targeted Microbiome Transplant in Atopic Dermatitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 28, 2017

Primary Completion Date

May 14, 2019

Study Completion Date

June 7, 2019

Conditions
Atopic Dermatitis (AD)
Interventions
BIOLOGICAL

TMT Lotion

TMT product and Vegetable glycerin-Cetaphil®

DRUG

Placebo Lotion

Cetaphil® moisturizing lotion and vegetable glycerin

Trial Locations (2)

80206

National Jewish Health General Clinical Research Center, Denver

92122

University of California - San Diego, San Diego

All Listed Sponsors
collaborator

Atopic Dermatitis Research Network

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT03151148 - Targeted Microbiome Transplant in Atopic Dermatitis | Biotech Hunter | Biotech Hunter